rs35364034
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_014962.4(BTBD3):c.909G>A(p.Ala303Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.057 in 1,614,150 control chromosomes in the GnomAD database, including 4,043 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.054 ( 369 hom., cov: 33)
Exomes 𝑓: 0.057 ( 3674 hom. )
Consequence
BTBD3
NM_014962.4 synonymous
NM_014962.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.908
Publications
11 publications found
Genes affected
BTBD3 (HGNC:15854): (BTB domain containing 3) Enables identical protein binding activity. Predicted to be involved in cerebral cortex development and dendrite morphogenesis. Predicted to be located in nucleus. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 20-11923006-G-A is Benign according to our data. Variant chr20-11923006-G-A is described in ClinVar as Benign. ClinVar VariationId is 1226908.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.908 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.246 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0538 AC: 8193AN: 152192Hom.: 373 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
8193
AN:
152192
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0734 AC: 18322AN: 249728 AF XY: 0.0740 show subpopulations
GnomAD2 exomes
AF:
AC:
18322
AN:
249728
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0573 AC: 83738AN: 1461840Hom.: 3674 Cov.: 31 AF XY: 0.0593 AC XY: 43094AN XY: 727216 show subpopulations
GnomAD4 exome
AF:
AC:
83738
AN:
1461840
Hom.:
Cov.:
31
AF XY:
AC XY:
43094
AN XY:
727216
show subpopulations
African (AFR)
AF:
AC:
1261
AN:
33480
American (AMR)
AF:
AC:
3660
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
1321
AN:
26136
East Asian (EAS)
AF:
AC:
10035
AN:
39700
South Asian (SAS)
AF:
AC:
9549
AN:
86258
European-Finnish (FIN)
AF:
AC:
1157
AN:
53368
Middle Eastern (MID)
AF:
AC:
428
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
52462
AN:
1112010
Other (OTH)
AF:
AC:
3865
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
5614
11228
16841
22455
28069
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2150
4300
6450
8600
10750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0538 AC: 8193AN: 152310Hom.: 369 Cov.: 33 AF XY: 0.0548 AC XY: 4081AN XY: 74488 show subpopulations
GnomAD4 genome
AF:
AC:
8193
AN:
152310
Hom.:
Cov.:
33
AF XY:
AC XY:
4081
AN XY:
74488
show subpopulations
African (AFR)
AF:
AC:
1601
AN:
41550
American (AMR)
AF:
AC:
975
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
148
AN:
3472
East Asian (EAS)
AF:
AC:
1335
AN:
5178
South Asian (SAS)
AF:
AC:
579
AN:
4832
European-Finnish (FIN)
AF:
AC:
192
AN:
10622
Middle Eastern (MID)
AF:
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3227
AN:
68030
Other (OTH)
AF:
AC:
110
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
397
795
1192
1590
1987
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
575
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 19, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.